Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue:
Total revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses:
Research and development	286,886	456,280	575,370	771,592
General and administrative	1,427,916	771,533	2,760,102	1,367,253
Total operating expenses	1,714,802	1,227,813	3,335,472	2,138,845
Loss from operations	(1,714,802)	(1,227,813)	(3,335,472)	(2,138,845)
Interest expense	(1,779,462)	(353,404)	(3,502,517)	(542,428)
Net loss	(3,494,264)	(1,581,217)	(6,837,989)	(2,681,273)
Other comprehensive loss:
Foreign currency translation adjustment	(107,151)	(19,333)	(117,857)	(14,510)
Comprehensive loss	$ (3,601,415)	$ (1,600,550)	$ (6,955,846)	$ (2,695,783)
Net loss per share, basic and diluted	$ (0.15)	$ (0.07)	$ (0.29)	$ (0.12)
Weighted average number of shares outstanding	23,308,049	22,390,114	23,209,514	21,638,907